Anastasia Gavrilova
Associate
Anastasia specialises in legal regulation of the healthcare industry. Her professional interests include legal regulation of medicines at all stages of the life cycle, including complex commercial law issues, intellectual property rights, promotion of medicines and complex regulatory issues.
Anastasia has experience in implementing projects in the digital health industry, including advising Russian and international companies on the regulation of personal data processing in the Russian Federation, telemedicine, as well as on other complex issues of creating and using digital products.
Anastasia has experience in implementing projects in the digital health industry, including advising Russian and international companies on the regulation of personal data processing in the Russian Federation, telemedicine, as well as on other complex issues of creating and using digital products.
achievemnts
Ratings and Awards
Anastasia graduated from the Faculty of Law of the National Research University Higher School of Economics and graduated with honours from the Master's programme ‘Legal Regulation in Pharmaceuticals and Biotechnology’.
Education
Anastasia completed her legal studies at the National Research University Higher School of Economics and earned a Master's degree with honors in “Legal Regulation in Pharmaceuticals and Biotechnology.”
projects
Selected project experience
Supporting on contractual and commercial law issues in the framework of entering international markets for COVID-19 vaccine.
Supporting a European pharmaceutical company in the client's office on day-to-day legal matters, including general legal advice, contractual work, promotional materials work.
Comprehensive legal support of a transaction involving the acquisition of rights to a medicinal product by a pharmaceutical company, including preparation of various types of agreements.
Advising international pharmaceutical companies on complex issues related to the organisation of clinical trials, from analysing options for structuring relationships between all parties involved to drafting the necessary agreements.
Advising pharmaceutical companies on work with personal data, including complex projects to build the entire system of work with personal data.
Participation in a project to support a major commercial dispute regarding the quality of medicines.
Comprehensive legal support in launching a telemedicine service, including analysing regulatory issues, personal data processing and contractual arrangements.
Advising pharmaceutical companies on public procurement of health care services.
Advising a pharmaceutical company on a transaction involving the transfer of drug production technology for the purpose of localisation of the full production cycle, starting from a substance, to a production site in Russia.
Supporting a European pharmaceutical company in the client's office on day-to-day legal matters, including general legal advice, contractual work, promotional materials work.
Comprehensive legal support of a transaction involving the acquisition of rights to a medicinal product by a pharmaceutical company, including preparation of various types of agreements.
Advising international pharmaceutical companies on complex issues related to the organisation of clinical trials, from analysing options for structuring relationships between all parties involved to drafting the necessary agreements.
Advising pharmaceutical companies on work with personal data, including complex projects to build the entire system of work with personal data.
Participation in a project to support a major commercial dispute regarding the quality of medicines.
Comprehensive legal support in launching a telemedicine service, including analysing regulatory issues, personal data processing and contractual arrangements.
Advising pharmaceutical companies on public procurement of health care services.
Advising a pharmaceutical company on a transaction involving the transfer of drug production technology for the purpose of localisation of the full production cycle, starting from a substance, to a production site in Russia.
what's new
News and publications